sulfamethoxazole has been researched along with Leukemia L 1210 in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rivard, GE | 1 |
| Momparler, LF | 1 |
| Momparler, RL | 1 |
1 other study available for sulfamethoxazole and Leukemia L 1210
| Article | Year |
|---|---|
Effects of trimethoprim on leukaemic cells in vitro.
Topics: Animals; Cell Survival; Cells, Cultured; Child; Deoxyuridine; Dose-Response Relationship, Drug; Huma | 1981 |